Rapid expansion of genotype D1.1 A(H5N1) influenza viruses in wild birds across North America during the 2024 migratory season
Tracking the emergence and rapid spread of D1.1 viruses in wild birds during the 2024 fall migration.
Reports
News
Scientific Papers
Avian Influenza Weekly Update Number 1039
This weekly situation report will highlight the most recent developments in the regional response.
Scientific Papers
News
Reports
Avian influenza overview December 2025–February 2026
Overview of highly pathogenic avian influenza (HPAI) virus detections in poultry and captive birds (domestic birds), as well as in wild birds, that occurred in and outside Europe between 29 November 2025 and 27 February 2026.
News
Policy & Recommendations
Europe strengthens lab defences against key pathogens
ESWI Chair Colin Russell was featured in a Medscape article on the EU reference laboratories aiming to improve disease surveillance data, including respiratory viruses.
SnotWatch: Mapping respiratory microbiology information to inform health outcomes
It collates data on health outcomes alongside laboratory results for virus tests. This creates a large and rich data platform, which will be used to accurately describe and predict health problems related to common viruses in the community.
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026
The European 2025/26 influenza season is dominated by the influenza A(H3N2) virus, with most sequenced viruses belonging to subclade K, genetically drifted from the vaccine virus, raising concerns around vaccine effectiveness.
Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026
In a pre-season influenza risk assessment publicly posted in October 2025, Canadian investigators used global genomic and antigenic surveillance data to highlight important mutations in circulating influenza A(H3N2) viruses.
Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season
Both viral and host factors have contributed to the intensity of influenza activity during the 2025–2026 season. Some of these factors can be managed, whereas others are largely beyond human control.